Sai Santosh Reddy Danda, Yi Lu Murphey, Amanda Maher, Carol Persad, Savannah Rose, Robert Koeppe, Bruno Giordani
{"title":"使用匝道驾驶预测淀粉样蛋白阳性的多模态机器学习。","authors":"Sai Santosh Reddy Danda, Yi Lu Murphey, Amanda Maher, Carol Persad, Savannah Rose, Robert Koeppe, Bruno Giordani","doi":"10.1002/dad2.70161","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Early detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.</p><p><strong>Methods: </strong>Driving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (<i>P ≤</i> 0.05) were used to train random forest and XGBoost classifiers to classify amyloid-positive and -negative participants, with feature importance evaluated based on model performance.</p><p><strong>Results: </strong>Integrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification.</p><p><strong>Discussion: </strong>Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection.</p><p><strong>Highlights: </strong>We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70161"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340426/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.\",\"authors\":\"Sai Santosh Reddy Danda, Yi Lu Murphey, Amanda Maher, Carol Persad, Savannah Rose, Robert Koeppe, Bruno Giordani\",\"doi\":\"10.1002/dad2.70161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Early detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.</p><p><strong>Methods: </strong>Driving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (<i>P ≤</i> 0.05) were used to train random forest and XGBoost classifiers to classify amyloid-positive and -negative participants, with feature importance evaluated based on model performance.</p><p><strong>Results: </strong>Integrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification.</p><p><strong>Discussion: </strong>Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection.</p><p><strong>Highlights: </strong>We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.</p>\",\"PeriodicalId\":53226,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"volume\":\"17 3\",\"pages\":\"e70161\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340426/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/dad2.70161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.
Introduction: Early detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.
Methods: Driving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (P ≤ 0.05) were used to train random forest and XGBoost classifiers to classify amyloid-positive and -negative participants, with feature importance evaluated based on model performance.
Results: Integrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification.
Discussion: Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection.
Highlights: We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.
期刊介绍:
Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.